Apyx Medical Corporation Class Action Lawsuit APYX | Deadline August 5, 2022

Apyx Medical Corporation (APYX) is facing a class action lawsuit (Apyx Medical Corporation Class Action Lawsuit) alleging that the Company made materially false and/or misleading statements and/or failed to disclose that:

(1) a significant number of Apyx’s Advanced Energy products were used for off-label indications; (2) such off-label uses led to an increase in the number of medical device reports filed by Apyx reporting serious adverse events; (3) as a result, the Company was reasonably likely to incur regulatory scrutiny; (4) as a result of the foregoing, the Company’s financial results would be adversely impacted; and (5) as a result of the foregoing, defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

If you incurred a loss on APYX stocks purchased between May 12, 2021 and March 11, 2022, this lawsuit is on your behalf. The lawsuit was filed in the United States District Court for the Middle District of Florida, and our firm is reaching out to investors to discuss their legal rights.

If you wish to act as a representative of the shareholders harmed by this misconduct, you may ask the court to appoint you as lead plaintiff. A lead plaintiff directs the litigation and participates in important decisions, including whether to accept a settlement for the class in the action.

You only have until August 5, 2022 to apply to be lead plaintiff. The court will then evaluate the applicants and choose a lead plaintiff. You are not required to act as a lead plaintiff in order to participate in any recovery.

Apyx Medical Corporation Class Action Lawsuit
Apyx Medical Corporation Lawsuit
APYX Class Action Lawsuit
APYX Lawsuit
Apyx Medical Corporation (APYX) Class Action Lawsuit

Apyx Medical Corporation Class Action Lawsuit,
Apyx Medical Corporation Class Action,
Apyx Medical Corporation Lawsuit,
APYX Class Action Lawsuit,
APYX Class Action,
APYX Lawsuit,
APYX stock